ライフサイエンスコーパス: perioperative

1 6%-39.5%), and 7.8% (95% CI, 7.1%-8.7%) were perioperative.

2 Perioperative administration of either probiotics or syn

3 To determine the cost-effectiveness of perioperative administration of pasireotide for reductio

4 l methods of identifying patients at risk of perioperative AKI may advance management and treatment o

5 Implementation of a perioperative allergy and antibiotic assessment tool in

6 le opioids constitute the major component of perioperative analgesic regimens for surgery in general,

7 ative setting analyses of cases of suspected perioperative anaphylaxis during general anaesthesia (GA

8 software in a large multicentral database of perioperative and critically ill patients and to use thi

9 We compared adjusted perioperative and long-term survival across quintiles of

10 re older than 65 years, achieving comparable perioperative and midterm results to younger donors.

11 For perioperative and oncologic outcome comparison, contempo

12 Perioperative and postoperative complications from all i

13 sity and end-stage organ disease and improve perioperative and postoperative outcomes.

14 ccess to transplant and unique challenges in perioperative and postoperative outcomes.

15 roved by the Committee for the Governance of Perioperative and Surgical Activities of the Hopital Mai

16 mal strategy; however, factors predictive of perioperative and survival outcomes are currently undefi

17 Recipients were treated perioperative and thereafter daily during 14 d with cibi

18 and nutrition, gastrointestinal, infection, perioperative, and neurology.

19 result in improved efficiencies surrounding perioperative antibiotic administration and possible red

20 Dysbiosis induced by brief perioperative antibiotic exposure attenuates weight loss

21 Cefazolin-based perioperative antibiotic prophylaxis is the guideline-re

22 Although perioperative anticoagulation approach was variable, hol

23 transplant surgery, and briefly address the perioperative approach to the pretransplant recipient on

24 To investigate perioperative approaches that mitigate IRI-induced tissu

25 t 6 weeks assessing users and optimizing all perioperative areas (scheduling, day of surgery, postop

26 Preoperative and perioperative aromatase inhibitor (POAI) therapy has the

27 After training, perioperative blood loss and length of stay improved, wh

28 After initiation of training, mean perioperative blood loss decreased (-255 mL, P<0.001), O

29 Perioperative blood transfusions are associated with sho

30 fants repaired later had significantly worse perioperative brain growth (late repair postoperative br

31 ps between clinical variables, brain injury, perioperative brain growth, and 18-month Bayley-III scor

32 ery ( P=0.007) were associated with impaired perioperative brain growth.

33 a predictive biomarker of patient outcome to perioperative cancer therapy and surgical resection in p

34 Perioperative cardiovascular complications are important

35 Perioperative cardiovascular complications occur in 3% o

36 in the chemotherapy regimens, as well as in perioperative care and surgical approach, have resulted

37 As perioperative care and surgical technique for hepatectom

38 These findings suggest that targeted perioperative care for HF subtypes may be crucial for th

39 flect the complex and multifaceted nature of perioperative care in patients with gastric adenocarcino

40 postoperative complications, the practice of perioperative care versus "pure surgery," and the effect

41 way of aerosol which may be generated during perioperative care.

42 mogram could improve delivery of appropriate perioperative care.

43 The EHR has become integral to perioperative care.

44 ntrality of personalized analgesia in modern perioperative care.

45 ore surgery is critical to ensure concordant perioperative care.

46 ed in a pronounced and sustained increase in perioperative cefazolin use.

47 ed a culture-independent strategy to monitor perioperative changes in microbial diversity of fecal sa

48 We observed reproducible perioperative changes in the skin microbiome following s

49 Indications, perioperative characteristics, and short and long-term o

50 Indications, perioperative characteristics, and short- and long-term

51 Perioperative chemotherapy has proven valuable in severa

52 y was to evaluate the efficacy and safety of perioperative chemotherapy in patients with locally adva

53 sectable stage IB-IIIA disease, and although perioperative chemotherapy is the standard of care, this

54 tment for patients with esophageal cancer is perioperative chemotherapy or preoperative chemoradiothe

55 carcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered.

56 02562716) was a randomized phase II study of perioperative chemotherapy with mFOLFIRINOX (Arm 1) or g

57 ose who had SCPC, anatomy, hemodynamics, and perioperative clinical outcomes were compared.

58 retransplant-free survival, despite greater perioperative complexity.

59 Perioperative complications and postoperative outcomes w

60 sed propensity score matching to compare the perioperative complications and postoperative short-term

61 is < 30% can be utilized with no increase in perioperative complications and similar patient and graf

62 n between neoadjuvant treatment strategy and perioperative complications in patients undergoing proct

63 tric bypass, and hysterectomy) who developed perioperative complications in the first few weeks of CO

64 ardized platform to collect European data on perioperative complications revealed that gastrectomy fo

65 No difference in any of the perioperative complications was seen between the mild ma

66 D-3L (EQ-5D-3L) score, morbidity, mortality, perioperative complications, and long-term operative out

67 Relevant risk factors for occurrence of perioperative complications, recurrences, and chronic pa

68 opportunity to use polygenic risk to predict perioperative complications.

69 There was no significant difference in perioperative complications.

70 cidence of ischemic cholangiopathy and other perioperative complications.

71 ssful surgical resection without prohibitive perioperative complications; (3) Completion of adjuvant

72 he aim of this study was to test whether the perioperative composition of intestinal microbiota can c

73 tidisciplinary strategy to create an optimal perioperative condition to finally lower CAL rates.

74 the effect of index surgical care setting on perioperative costs and readmission rates across 4 commo

75 COVID-19 can complicate the perioperative course with diagnostic challenge and a hig

76 Patient selection, perioperative data (severe complications, mortality, and

77 Europe and Australia prospectively collected perioperative data by carrying out the LekCheck, a short

78 s given access to a dedicated website, where perioperative data were prospectively collected.

79 Prospective baseline and perioperative data were retrieved from the Dutch Pancrea

80 Demographic and perioperative data were reviewed, and the potential risk

81 Perioperative data, technical information, treatment out

82 ry bypass who had a moderate-to-high risk of perioperative death.

83 ome was procedural (30 days, in-hospital, or perioperative) death or stroke.

84 There were no perioperative deaths or conversions to replacement.

85 f standard operating procedures could change perioperative decision making with regard to extending r

86 Interviews explored perioperative decision-making by asking surgeons to thin

87 mportant themes regarding the main topic of "perioperative decision-making" included many considerati

88 Guidelines for investigation of perioperative drug allergy exist, but the quality of ser

89 We aimed to establish whether perioperative eltrombopag was non-inferior to intravenou

90 Two hundred forty-two perioperative enhancements were completed.

91 Perioperative events surrounding major amputation were o

92 analyses to evaluate clinicopathological and perioperative factors for associations with major compli

93 Three perioperative factors impair host defence against recurr

94 Perioperative factors included cardio pulmonary bypass,

95 n groups (year 2016) for epidemiological and perioperative feature.

96 s standard practice, which may contribute to perioperative fluid overloading.

97 output of 0.5 mL/kg is a key target guiding perioperative fluid therapy.

98 Perioperative FOLFOX chemotherapy did not improve major

99 adjuvant FOLFOX after colectomy (control) or perioperative FOLFOX for 4 cycles before surgery and 8 c

100 Perioperative FOLFOX for locally advanced resectable CC

101 However, perioperative FOLFOX induces pathological regression and

102 RAS wild-type patients, a third arm testing perioperative FOLFOX-cetuximab was added.

103 systemic therapy delivered in a neoadjuvant/perioperative format for resectable PDA.

104 s; (3) Completion of adjuvant therapy in the perioperative format is difficult; (4) Major pathologic

105 In the FOLFOX perioperative group, 96% received the scheduled 4 cycles

106 with renal dysfunction; however, the tenuous perioperative hemodynamic and metabolic milieu in high a

107 with renal dysfunction; however, the tenuous perioperative hemodynamic and metabolic milieu in high-a

108 e University Hospitals who had experienced a perioperative hypersensitivity reaction clinically sugge

109 ions for the investigation of immediate-type perioperative hypersensitivity reactions and to provide

110 ) using IL-1alphabeta knockout (KO) mice and perioperative IL-1 receptor type 1 (IL-1R1) blockade wit

111 Perioperative immediate hypersensitivity reactions are r

112 Although studies have shown that perioperative IMN may reduce postoperative infectious co

113 rioperative period with specific emphasis on perioperative infections, wound healing, vascular compli

114 Perioperative interventional research to reduce the anti

115 Bundled perioperative interventions reduce colorectal SSI rates

116 ing day or surgery productivity, few include perioperative interventions to improve efficiencies.

117 OVID-19 pandemic on deferral of surgical and perioperative interventions, but these lack specific par

118 is thus required with the off-label use of a perioperative intravenous n-3 PUFA emulsion as a standal

119 We aimed to investigate the effects of perioperative intravenous n-3 PUFAs on inflammatory cyto

120 As an alternative, perioperative intravesical chemotherapy is recommended f

121 This prospective study evaluated perioperative lung resection outcomes after implementati

122 th low risk (<1%) and higher risk (>=1%) for perioperative major adverse cardiovascular events during

123 obiliary anatomy and the need for meticulous perioperative management especially in patients with adv

124 ny variables including patient, disease, and perioperative management factors have been shown to impa

125 Perioperative management is challenging in cirrhotic pat

126 Perioperative management of antiplatelet therapy, which

127 ients transplanted with pfDSA, consisting of perioperative management of DSA (polyvalent immunoglobul

128 POD1, suggesting room for improvement in the perioperative management of these patients.

129 iled descriptions of the surgical procedure, perioperative management, a determination of exocrine pa

130 es and improvements in patient selection and perioperative management, survival has steadily increase

131 endpoint in studies assessing the impact of perioperative management.

132 cessful outcomes without any modification to perioperative management.

133 mia-like episodes, and therefore appropriate perioperative measures are recommended.

134 Perioperative medical therapy should be prescribed based

135 he results from the testing would change the perioperative medical, anesthesia, or surgical approache

136 Despite significant advances in perioperative medicine, a significant portion of patient

137 he different techniques result in comparable perioperative morbidity and long-term survival.

138 Overall survival (OS) and perioperative morbidity and mortality were compared acro

139 There were no intergroup differences in perioperative morbidity and mortality, including rates o

140 improved OS, without an associated increased perioperative morbidity or mortality.

141 Secondary endpoints were toxicity, perioperative morbidity, and quality of surgery.

142 mes after total gastrectomy, without greater perioperative morbidity.

143 ot total open AAA volume was associated with perioperative mortality (lowest quintile of juxtarenal v

144 ation rates, overall 73.3% versus 67.9%, and perioperative mortality 4% versus 6.4%.

145 Perioperative mortality after iTAA repair was 4.9%; comb

146 ctive surgical removal with a reasonably low perioperative mortality at experienced centers.

147 stic regression to compare adjusted rates of perioperative mortality based on the day of repair.

148 When perioperative mortality exceeded 5.2% or yearly recurren

149 e 58 years, 63% female), hospital costs, and perioperative mortality from the Nationwide Inpatient Sa

150 Perioperative mortality in the last 23 consecutive cases

151 open juxtarenal repair demonstrated adjusted perioperative mortality of 9.0%, 4.9%, and 3.9%, respect

152 In patients with high risk of perioperative mortality or recurrence, watchful waiting

153 is a concern, current data indicate that the perioperative mortality rates range from 0.03% to 0.2%,

154 n abdominal aortic aneurysm results in lower perioperative mortality than traditional open repair, bu

155 The 30-day perioperative mortality was 2.3% (1/ 44 ablations).

156 After rTAA repair, perioperative mortality was 26.8%.Mortality was 9.7% aft

157 Perioperative mortality was assessed with logistic regre

158 Propensity-weighted perioperative mortality was similar between open repair

159 The odds of perioperative mortality were greater for open surgical r

160 able CRLM treated by ALPPS have not only low perioperative mortality, but achieve appealing long-term

161 gher overall survival than FEVAR and similar perioperative mortality, but longer lengths of stay, and

162 olumes of open juxtarenal repair have higher perioperative mortality, irrespective of their total ope

163 feasible and safe without increased risk of perioperative mortality.

164 pancreatectomy group with no differences in perioperative mortality.

165 Perioperative music also significantly reduced intraoper

166 Perioperative music can reduce opioid and sedative medic

167 ontrolled trials investigating the effect of perioperative music on medication requirement, length of

168 Perioperative music significantly reduced postoperative

169 studies have reported beneficial outcomes of perioperative music.

170 There is a greater risk of perioperative myocardial infarction and major adverse ca

171 ically significant difference in the risk of perioperative myocardial infarction between the 2 cohort

172 0, renal-replacement therapy through day 30, perioperative myocardial infarction through day 5, or us

173 her complications such as delirium and other perioperative neurocognitive disorders.

174 d treatment can be helpful in minimizing the perioperative neurological risk for individual patients.

175 Team (CQIT) of surgical quality officers and perioperative nurses was organized to perform structured

176 The PIONEER Intraoperative and Perioperative OCT Study is a prospective cohort, institu

177 of evidence points to an association between perioperative opioid exposure and longer term oncologic

178 tical need to identify best practices around perioperative opioid prescribing.

179 d; 54.6% of opioid naive patients received a perioperative opioid prescription.

180 We present a holistic perioperative optimization approach led by a CI team wit

181 Perioperative or adjuvant chemotherapy improves survival

182 e the impact of opioid use disorder (OUD) on perioperative outcomes after major upper abdominal surge

183 Perioperative outcomes and 5-year OS were compared.

184 The most common focus of study was perioperative outcomes and complications (46.7%).

185 Secondary endpoints included intra- and perioperative outcomes and graft and patient survival.

186 study was to obtain estimates of changes in perioperative outcomes and utilization of bariatric surg

187 lly representative information on changes of perioperative outcomes and utilization of surgery in the

188 omorbidities, operative characteristics, and perioperative outcomes by race and ethnicity.

189 is study was to evaluate trends over time in perioperative outcomes for patients undergoing hepatecto

190 fewer intraoperative transfusions and better perioperative outcomes for PD.

191 to decrease transfusions and provide better perioperative outcomes in PD.

192 ased surgical safety checklists in improving perioperative outcomes in research trials, effective met

193 However, the perioperative outcomes of PLDRH have not been fully eval

194 Whether these PREs data correlate with perioperative outcomes remains ill defined.

195 Patients and perioperative outcomes were analyzed.

196 inued improvements in surgical technique and perioperative outcomes yielded a resultant decrease in C

197 Patient characteristics, perioperative outcomes, and survival were evaluated.

198 Perioperative outcomes, including the comprehensive comp

199 assess the impact of pouch reconstruction on perioperative outcomes, postprandial symptoms, nutrition

200 treated at high-volume centers had improved perioperative outcomes, short-term mortality, and overal

201 sed to identify associations between EBL and perioperative outcomes.

202 lood loss significantly correlated with poor perioperative outcomes.

203 TVP category, oncologic care processes, and perioperative outcomes.

204 l teaching intensity, Medicare payments, and perioperative outcomes.

205 Demographics, operative data, perioperative pain medication use, and discharge pain me

206 The current study aimed to pilot the Perioperative Pain Self-management (PePS) intervention,

207 From 2013 to 2017, pre, intra, and perioperative pancreatectomy processes have evolved, and

208 Several perioperative parameters were collected.

209 March 2017 were managed with a standardized perioperative pathway according to ERAS principles.

210 ERAS perioperative pathways have been recently applied to eso

211 For inpatients and perioperative patients, administrations of antibiotics w

212 The immediate perioperative period (days before and after surgery) is

213 se, 19 (2.0%) occurred during the intra- and perioperative period and 44 were late complications (4.7

214 uria and antimicrobial initiation during the perioperative period and assess harms versus benefits of

215 medications and behavioral therapies in the perioperative period for these higher risk patients.

216 ious strategies for managing DAPT during the perioperative period have been proposed.

217 devastating condition that can occur in the perioperative period resulting in paraplegia.

218 an updated review on the role of NETs in the perioperative period with specific emphasis on periopera

219 wel disease, patient blood management in the perioperative period, and obstetrics and gynaecology.

220 ch as unusual site thrombosis, bleeding, the perioperative period, and pregnancy, are especially chal

221 als, and their functions are relevant in the perioperative period.

222 ens to reduce reliance on opioids during the perioperative period.

223 3.3 to 1.4); most deaths occurred during the perioperative period.

224 Detailed intraoperative and perioperative physiological parameters, including heart

225 atients at risk for PPM will help facilitate perioperative planning and inform clinical decision maki

226 Perioperative plasmapheresis increased the risk for tran

227 ement of DSA (polyvalent immunoglobulins +/- perioperative plasmapheresis sessions, according to DSA

228 The primary outcome was achievement of perioperative platelet count targets (90 x 10(9) cells p

229 In the per-protocol analysis, perioperative platelet targets were achieved for 29 (78%

230 By intention-to-treat analysis, perioperative platelet targets were achieved for 30 (79%

231 This study identified 7 perioperative potentially modifiable risk factors for CA

232 gression analysis were performed to identify perioperative potentially modifiable risk factors for CA

233 e location, and Society of Thoracic Surgeons perioperative predicted risk of morbidity or mortality o

234 Higher Society of Thoracic Surgeons perioperative predicted risk was associated with signifi

235 er, there is insufficient evidence to inform perioperative prescribing guidelines and quality metrics

236 Cataract surgery patients who had a perioperative prescription of topical NSAIDs filled in a

237 rkflow efficiency, all who contribute to the perioperative process must be assessed.

238 t, compared to the additional application of perioperative prophylaxis (aHR 2.87, 95% CI 1.17 - 7.05)

239 iciency (aHR 4.85, 1.20 - 19.61); inadequate perioperative prophylaxis in patients with an establishe

240 We identified procedure time; inadequate perioperative prophylaxis, especially among patients wit

241 In conclusion, a perioperative protocol restricting RBC transfusion succe

242 For perioperative quality improvement interventions to compe

243 rt study examines association between use of perioperative RASi and outcomes in patients undergoing c

244 ry for PDAC is eminently feasible within the perioperative recovery period, enabling the potential fo

245 PMEG were associated with similar perioperative results as commercially available FEVAR, b

246 e coronary revascularization does not reduce perioperative risk and should not be performed without s

247 ereas discharge to a facility and increasing perioperative risk correlate with worse long-term PRO.

248 ment with a parsimonious risk model improved perioperative risk estimation.

249 r patients with long life expectancy and low-perioperative risk may benefit more from open repair.

250 Candidates who accepted had a brief perioperative risk period within the first month posttra

251 Candidates who accepted had a brief perioperative risk period within the first month posttra

252 perception that RYGB has prohibitively-high perioperative risks among CKD patients is disputable and

253 The short-term perioperative risks and longer term functional value of

254 B based on perceptions of prohibitively-high perioperative risks surrounding RYGB.

255 Perioperative safety of bariatric surgery improved over

256 However, the perioperative safety of bariatric surgery in this patien

257 To validate consensus equation in a perioperative setting analyses of cases of suspected per

258 s a reference for optimal PPE choices in the perioperative setting for surgical teams.

259 noperable metastatic disease, its use in the perioperative setting in patients with operable disease

260 nonanaphylactic and anaphylactic events in a perioperative setting when acute and baseline levels wer

261 Anemia is a common finding in the perioperative setting with significant untoward conseque

262 ich may lack specificity or relevance in the perioperative setting.

263 rential diagnoses to hypersensitivity in the perioperative setting.

264 ing the important role of TLR4 system in the perioperative settings, these findings suggest the possi

265 e (odds ratio 4.47 [95% CI 1.46-13.65]), and perioperative severe obstetric haemorrhage (5.87 [1.99-1

266 Perioperative side-effects were negligible; one patient

267 ic conditions, including those affecting the perioperative space.

268 There may be a role for perioperative steroids in patients with a history of uve

269 These data may inform perioperative stewardship.

270 CRLMs, which may be used to plan better the perioperative strategies to reduce the incidence of R1 r

271 me uncertainty regarding the most beneficial perioperative strategy for patients with CAD.

272 Pharmacological control of excess perioperative stress-inflammatory responses has been sho

273 ive strategies aimed at reducing the risk of perioperative stroke and at improving the outcomes of pa

274 primary endpoint was the combined outcome of perioperative stroke and/or death.

275 Based on the timing of onset and detection, perioperative stroke can be classified as intraoperative

276 Several trials have observed higher rates of perioperative stroke following transfemoral carotid arte

277 The pathogenesis of perioperative stroke is multifactorial, which makes pred

278 Perioperative stroke is one of the most severe and feare

279 ng the outcomes of patients who experience a perioperative stroke.

280 pled with inconsistencies in the practice of perioperative surgical wound care, increases patients' r

281 Patients underwent perioperative testing for changes in neurofilament light

282 Blood was sampled at 6 perioperative time points for changes in cytokines in se

283 y, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dissection, Concur

284 y, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dissection, Concur

285 s the need for early intervention to prevent perioperative tissue injury to transplantable organs.

286 On multivariate analysis, perioperative TKI use was independently associated with

287 Intra-, post-, and perioperative transfusion rates were 15.8%, 24.8%, and 3

288 .61, p < 0.001) CC volumes following complex perioperative treatment for LGEA in both full-term and p

289 , a phase III randomized controlled study of perioperative treatment in patients with operable gastri

290 implantation strategy, and preoperative and perioperative treatment is applied at our institution.

291 lternative to intravenous immunoglobulin for perioperative treatment of immune thrombocytopenia.

292 e discuss apparent contraindications for the perioperative use of cancer immunotherapy, suggest safe

293 Routine perioperative use of low-dose aspirin (100 mg/d) does no

294 The results suggest that perioperative use of RASi has a significant benefit for

295 It remains disputable about perioperative use of renin-angiotensin system inhibitors

296 Our goal is to determine whether the perioperative use of TKIs increases the postoperative mo

297 to the creation of the anastomosis to check perioperative values on 1) general condition 2) local pe

298 rolled Trial; NCT00800137) demonstrated that perioperative warfarin continuation reduced clinically s

299 riven initiative resulted in improved FCOTS, perioperative workflows, and user satisfaction.

300 m(2)) were at significantly reduced risk for perioperative wound complications (Odds Ratio 0.400 [95%